Document is current

Article History

First Online: 31 January 2025

Declarations

:

: Any data generated will be available upon request to the corresponding authors.

: The authors declare the following competing interest: Both authors, Leela Raghava Jaidev Chakka (LJC) and Mohammed Maniruzzaman (MM) are co-inventors of related intellectual property (IP). M.M., an author of this manuscript, holds stock in, serves on a scientific advisory board for, or is a consultant for CoM3D Ltd. (Surrey, UK), DosePlus Therapeutics, Inc. (Princeton, NJ, USA), and Septum Solutions LLC (Houston, TX, USA). The terms of this arrangement have been reviewed and approved by the University of Texas at Austin and the University of Mississippi (Ole Miss) in accordance with their policies on objectivity in research. The companies had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; and in the decision to publish the results.

: No funding sources to declare.

: The authors acknowledge the University of Mississippi and School of Pharmacy for the administrative and infrastructure facilities.